ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2013
Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations.Movement disorders : official journal of the Movement Disorder Society · 2025Pooled it
- Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.Movement disorders : official journal of the Movement Disorder Society · 2018Pooled it
- Does Right-Hand Motor Impairment Affect Performance on Cognitive Testing in Parkinson's Disease?Movement disorders clinical practice · 2025Article
- A multi-site study on sex differences in cortical thickness in non-demented Parkinson's disease.NPJ Parkinson's disease · 2024Article
- Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.Neurology · 2021Article
- Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.Journal of Parkinson's disease · 2021Article
- Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.Neuropathology and applied neurobiology · 2020Article
- Multimodal in vivo and postmortem assessments of tau in Lewy body disorders.Neurobiology of aging · 2020Article
- Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Movement disorders : official journal of the Movement Disorder Society · 2020Article
- Characterization of cognition in mild cognitive impairment with and without Parkinson's disease.Clinical parkinsonism & related disorders · 2020Article
- Hallucinations and Development of Dementia in Parkinson's Disease.Journal of Parkinson's disease · 2020Article
- Episodic recognition memory and the hippocampus in Parkinson's disease: A review.Cortex; a journal devoted to the study of the nervous system and behavior · 2019Review
- Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.Annals of neurology · 2019Article
- A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.Journal of Parkinson's disease · 2017Article
- Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).Journal of Parkinson's disease · 2016Article
- Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease.Movement disorders : official journal of the Movement Disorder Society · 2015Article
- Longitudinal study of normal cognition in Parkinson disease.Neurology · 2015Article
- Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.Parkinsonism & related disorders · 2015Article
- Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics.Journal of Parkinson's disease · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cognitive impairment (CI) and behavioral disturbances can be the earliest symptoms of Parkinson's disease (PD), ultimately afflict the vast majority of PD patients, and increase caregiver burden. Our two Morris K. Udall Centers of Excellence for Parkinson's Disease Research were supported by the National Institute of Neurological Disorders and Stroke (NINDS) in an effort to recommend a comprehensive yet practical approach to cognitive and behavioral assessment to further collaborative research. We recommend a stepwise approach with two levels of standardized evaluation to establish a common battery, as well as an alternative testing recommendation for severely impaired subjects, and review supplemental tests that may be useful in specific research settings. Our flexible approach may be applied to studies with varying emphasis on cognition and behavior, does not place undue burden on participants or resources, and has a high degree of compatibility with existing test batteries to promote collaboration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.